---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-22-000107"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2022-06-14T23:59:59+00:00"
generated_at: "2026-06-25T01:50:15.208095+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics names Sam Samad as EVP & CFO, effective July 25, 2022

## Summary
- Samad joins from Illumina (CFO since 2017); start date July 11, CFO role effective July 25.
- Base salary $650k; target annual incentive 90% of base; initial equity grant $2.5M (50% performance shares, 25% options, 25% RSUs).
- Sign-on inducement: cash payment of $1.2M (refundable if voluntary exit within 2 years) and RSUs valued at $1.5M vesting over 2 years.
- Outgoing CFO Mark Guinan remains through Q2 earnings report for transition.
- Samad eligible for executive severance plan, relocation benefits up to $105k, and share ownership guideline of 4x base salary.

## SEC filing metadata
- accession: 0001022079-22-000107
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2022-06-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/dgx-20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-22-000107
- JSON: https://secwatch.observer/filing/0001022079-22-000107.json
- Plain text: https://secwatch.observer/filing/0001022079-22-000107.txt

## Key facts
- Executive change
  Sam Samad was appointed as Executive Vice President and Chief Financial Officer at QUEST DIAGNOSTICS INC.
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: On June 9, 2022, Quest Diagnostics Incorporated (the “Company”) announced that Sam Samad will become Executive Vice President and Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm
- Executive change
  Mark Guinan departed as Chief Financial Officer at QUEST DIAGNOSTICS INC.
  - Action: announced retirement
  - Role: Chief Financial Officer
  source text: Mr. Samad succeeds Mark Guinan, who, in February 2022, announced his decision to retire.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.